The Cannabis Society Business Conference @NortheasternU (Toronto)
Northeastern University - Toronto
100 King St W, Toronto, ON M5X 1A9, Canada
Toronto
Ontario
43.64863620000001
-79.3817439
Description
The Cannabis Society. Who Are We?
The Cannabis Society is dedicated to fostering the cannabis community through events, conferences, dinners, & many more. Join us together with Industry experts, entrepreneurs, investors and service providers for Cannabis Business Conference on October 29th at Northeastern University (Toronto).
Tentative Schedule (Subject to change as speakers are added):
5:45pm: Registration & Deal making
6:00pm: Opening remarks from The Cannabis Society
6:20: Keynote by Niel Marotta- President, CEO, Director & Founder at Indiva.
6:40: Keynote by Dr. Stephen F. Amato - Faculty Director of Graduate Regulatory Affairs/Quality Assurance/Advanced Manufacturing at Northeastern University,
7:10: Break
7:20: Keynote by Stephen Verbeek- CEO of Hello Cannabis
7:40: Marketing cannabis post legalization with Tara Martin, Jay Berard, Mitchell Osak and Eric Vengroff.
8:00pm: Cannabis Global Market with Nick Pateras, Aliza Lakhani, Robyn Rabinivich, Brennan Kerr.
8:20pm: Reception & Deal making
9:00pm: Event Conclusion
Speakers and more event details coming soon!
Niel Marotta - President, CEO, Director & Founder at Indiva. Niel was a top performing fund manager at a prominent US firm, where he managed a portfolio of over $1 Billion across several industries. He also served as Vice President for a TSX listed natural resource focused company. Subsequently, Niel worked as an investment banker, and has been involved in financings and M&A transactions exceeding $1 Billion. Niel is a graduate of McGill University’s commerce program.
Dr. Stephen F. Amato has over 25 years of experience in the pharmaceutical, biotechnology and medical device industries. Prior to his position as Faculty Director of Graduate Regulatory Affairs/Quality Assurance/Advanced Manufacturing at Northeastern University, Steve was the Founder and Managing Director of tJun17 Life Science Advisors, LLC, and also a Managing Director for Cardinal Health Regulatory Sciences (CHRS). As an Executive Director at Anika Therapeutics Steve managed all aspects of the company's product portfolio including regulatory, reimbursement, market segmentation, targeting, positioning, pricing and promotional strategies. From 2000 to 2007 he was the Group Director of Biologics and Knee Repair at Smith & Nephew Endoscopy where he managed a $200 M orthopedic product portfolio. Earlier in his career, Steve worked for Visible Genetics/Siemens Healthcare, where he was responsible for developing and launching genomic molecular diagnostics products used for subtyping Human Papilloma Virus (HPV) and other infectious disease agents. He has also worked with Critical Therapeutics on the development and commercialization of treatments for gram-negative sepsis.Steve holds an AB in Biochemical Sciences from Harvard University, a Ph.D. in Molecular and Cellular Biology from Boston College’s Graduate School of Arts & Sciences, and an MBA from the Carroll School of Graduate Management at Boston College.
Aliza Lakhani is CEO and Dean of Northeastern University Toronto. Headquartered in Boston and ranked Top 40 by US News, Northeastern University is a leader in experiential education and lifelong learning. Toronto is Northeastern’s first international campus, and part of the network of campuses across North America - other physical campuses include Silicon Valley, Seattle and Charlotte. Most recently, Aliza was head of Business Development and International at The DMZ at Ryerson University, the #1 ranked university tech incubator in the world. Under Aliza’s direction, the DMZ tripled annual revenue through corporate partnerships with Fortune 500 companies and expanded into global markets, including opening an office in New York City. While at the DMZ, she also advised a number of startups on enterprise sales and commercialization opportunities. Aliza spent more than a decade in Financial Services in Canada and the U.S., including several years at the Bank of Montreal in progressively senior roles.
Eric Vengroff is the CEO of 21 Ton NOC, Inc., a boutique digital customer acquisition firm. He is also Senior Financial Analyst for Cannabis Daily, a news and information website for cannabis industry investors. Eric and his partner Andrew Shaw founded Cannabis Daily in March, 2018 in response to growing client demand for advertising and promotion in the cannabis space. With heavy national and international restrictions on digital electronic communication with respect to cannabis by the major advertising platforms, growers, retailers and related businesses need a professional, acceptable, and presentable site from which and through which they can publicize their activities. Cannabisdaily.today provides this medium.
Nick Pateras is Vice President of Strategy at Lift & Co. (TSXV: LIFT), Canada's leading cannabis media and technology platform. Lift & Co.’s mission is to empower better cannabis decisions by bridging the informational gap between buyers and sellers.Prior to joining Lift & Co., Nick spent several years in the pharmaceutical sector with Johnson & Johnson Inc. His background in healthcare led him to make the professional move into cannabis, having long advocated for recognition of its many medical applications. Nick is a regular speaker at cannabis conferences across North America and Europe and teaches the Cannabis Business Fundamentals course at George Brown College. He holds two degrees, in Business and Philosophy, from Queen's University, Canada.
Tara Martin is the co-Founder of JADEO. Tara has been creating exceptional customer experiences and product success for leaders like AT&T, Gap Inc., IDEO, frog design, Google, and SickKids. Her recent strategic UX accomplishments include the SickKids VS platform which resulted in numerous global awards including a Clio, a Pencil, and a Cannes Lion, but more importantly, brought in over 600 million dollars for the hospital. In late 2017 Tara shifted her interest from agency-side life to client-side and became the Co-Founder and CPO at JADEO, the first online Cannabis-Based Wellness Information hub that welcomes wellness seekers/supporters, patients, businesses, and professionals.
Robyn Rabinovich (Vice President of Business Strategy, TerrAscend Corp.) brings a wealth of experience from the cannabis industry with four years of experience in the space. From business development, to procurement of quality product, promotion and compliance within the Cannabis Act, she levers her knowledge and experience to strategically evaluate business development opportunities within Canada and internationally. Robyn obtained her International Business degree from Dalhousie University.
Jay Berard is the Founder and President of Jagger - A modern headhunting firm built for today's talent market. Jay has consulted with over 200 companies globally to help them identify and acquire the right talent to help accomplish their goals. Through their modern approach and philosophy, Jagger has grown more than 100% YOY and is continuously driven to help companies in multiple industries fulfill one mission. Find. Great. People.
Mitchell Osak is the Managing Director of Grant Thornton's Business Consulting practice. He has over 25 years of senior consulting and operating experience in a variety of organizations under diverse operating and market conditions. Mitchell is considered a North American thought leader in the areas of strategy development, organizational design, digital transformation and performance improvement. He is regularly asked to comment on the cannabis industry in both national and trade media on topics such as marketing/branding, M&A and operating model design.
Robyn Rabinovich is a VP of Business Strategy for TerrAscend . She has extensive experience in the cannabis space. Her knowledge supports her ability to evaluate business development opportunities within Canada and across the globe. Robyn obtained her International Business degree from Dalhousie University.
Stephen Verbeek is a Chartered Investment Manager holder (CIM) and began his career as an Investment Executive at ScotiaMcLeod and RBC DS for 11 years. As a Co-Founder and Director of Huxton Black Ltd. an exempt market dealer and hybrid robo advisor investment firm based out of Hamilton, Ontario, Stephen is an opioid survivor after sustaining bi-lateral calcaneus fractures (shattering one’s feet) in a fall. He lives with 17 screws and 2 plates in his feet and has been opioid free for 5 years. He was prescribed 6 mg of dilaudid every 4 hours to cope with his pain and was fortunately able to quit after two months. Stephen is adamant that this process would not have been possible without the use of medical cannabis which he still currently uses to manage pain and insomnia. He acquired an MMAR license in 2013 which allowed him to build a skillset in both cannabis and finance which is where he dedicates his professional time today. After volunteering at the fracture clinic and fostering relationships with local physicians and surgeons, the concept of Hello Cannabis, Goodbye Opioids was started. Stephen is now the Founder and Chairman of Hello Cannabis Medical Education Centres which specialize in assisting patients acquiring a legal medical cannabis prescription, as well as educating them on the products that they likely have the highest efficacy for, in terms of treating their ailments. This has expanded into educating physicians and labour unions on the benefits of medical cannabis use and highlighting the risks and benefits of consumption. Stephen is also the Founder and former President of Cannoleum Inc. (now GR Genetics) a Canadian Cannabis corporation focused exclusively on medical cannabis and genetic research/cultivation and propagation which was acquired by another local limited partnership
Brennan Kerr is a Consultant, Business Development for Cannabis Compliance Inc (CCI). He has over 10 years experience in business development and strategic sales across several industries including cannabis, tech and sports & entertainment. At CCI, Brennan is responsible for diagnosing challenges of cannabis projects in the Canadian market - as well as new emerging international markets - and leveraging CCI’s expert solutions (licensing, GMP compliance, audit, recruitment, supply agreements etc.). Brennan has a business degree from Queen’s University and a cannabis business certification from Durham College.
Gold Partner:
Silver Partner:
Bronze Partner:
This listing has no upcoming events
Start:
2018-10-29T18:00:00-04:00
End:
2018-10-29T21:00:00-04:00
Category
Business
Tickets
Early Bird - General Admission
38.32
CAD
1
General Admission
76.06
CAD
75
Advanced - General Admission
76.06
CAD
1